SpyGlass Pharma, Inc. (SGP)

NASDAQ: SGP · Real-Time Price · USD

36.75

+2.67 (7.83%)

At close: Nov 6, 2026, 4:00 PM EST

37.59

+0.84 (2.29%)

After-hours: Nov 6, 2026, 6:59 PM EST

SpyGlass Pharma Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Income	-62.11	-41.45	-27.06
Net Income	-56.05	-39.87	-29.16
Earnings Per Share	-3.88	-17.98	-16.31
EPS Growth	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	234.19	107.44	16.27
Total Debt	1.63	1.58	3.9
Net Cash (Debt)	232.55	105.85	12.37
Net Cash Growth	1779.83%	755.66%	-
Net Cash Per Share	16.09	47.74	6.92

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-46.56	-32.7	-22.03
Capital Expenditures	-3.18	-0.79	-1.99
Free Cash Flow	-49.74	-33.49	-24.02
Free Cash Flow Growth	-	-	-